Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Connected Inhaler System adherence study with Relvar/Breo Ellipta in poorly controlled asthma
2017-002266-45Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate + vilanterol in asthma (2 arms), sponsored by GSK. Started Oct 2017; status: completed.
02
Drugs
fluticasone propionate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2017-002266-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002266-45.